Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Vink

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Journal of Neurotrauma|December 24, 2010
A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injuryJames J Donkin, Ibolja Cernak, Peter C Blumbergs, et al.
Progress in Brain Research|July 10, 2007
Substance P in traumatic brain injuryJames J Donkin, Renee J Turner, Islam Hassan, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 18, 2002
Temporal characterisation of pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in ratsIbolja Cernak, Sarah M Chapman, Gary P Hamlin, et al.
Molecules (Basel, Switzerland)|September 30, 2010
Kinin receptor antagonists as potential neuroprotective agents in central nervous system injuryEmma Thornton, Jenna M Ziebell, Anna V Leonard, et al.
Journal of the American College of Nutrition|October 7, 2004
Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in ratsLisa Fromm, Deanne L Heath, Robert Vink, et al.
Recent Patents on CNS Drug Discovery|November 12, 2014
Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide Substance P and its antagonists as anti-cancer agentsKimberley Mander, Elizabeth Harford-Wright, Kate M Lewis, et al.
Neuroscience Letters|December 21, 2002
Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in ratsRobert Vink, Christine A O'Connor, Alan J Nimmo, et al.
Plos One|May 14, 2014
Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumorsElizabeth Harford-Wright, Kate M Lewis, Mounir N Ghabriel, et al.
Anti-Cancer Drugs|February 15, 2013
NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancerKate M Lewis, Elizabeth Harford-Wright, Robert Vink, et al.
Legal Medicine (Tokyo, Japan)|March 24, 2009
How rapidly does cerebral swelling follow trauma? Observations using an animal model and possible implications in infancyRoger W Byard, Kartik D Bhatia, Peter L Reilly, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Journal of Neurotrauma|December 24, 2010
A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injuryJames J Donkin, Ibolja Cernak, Peter C Blumbergs, et al.
Progress in Brain Research|July 10, 2007
Substance P in traumatic brain injuryJames J Donkin, Renee J Turner, Islam Hassan, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 18, 2002
Temporal characterisation of pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in ratsIbolja Cernak, Sarah M Chapman, Gary P Hamlin, et al.
Molecules (Basel, Switzerland)|September 30, 2010
Kinin receptor antagonists as potential neuroprotective agents in central nervous system injuryEmma Thornton, Jenna M Ziebell, Anna V Leonard, et al.
Journal of the American College of Nutrition|October 7, 2004
Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in ratsLisa Fromm, Deanne L Heath, Robert Vink, et al.
Recent Patents on CNS Drug Discovery|November 12, 2014
Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide Substance P and its antagonists as anti-cancer agentsKimberley Mander, Elizabeth Harford-Wright, Kate M Lewis, et al.
Neuroscience Letters|December 21, 2002
Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in ratsRobert Vink, Christine A O'Connor, Alan J Nimmo, et al.
Plos One|May 14, 2014
Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumorsElizabeth Harford-Wright, Kate M Lewis, Mounir N Ghabriel, et al.
Anti-Cancer Drugs|February 15, 2013
NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancerKate M Lewis, Elizabeth Harford-Wright, Robert Vink, et al.
Legal Medicine (Tokyo, Japan)|March 24, 2009
How rapidly does cerebral swelling follow trauma? Observations using an animal model and possible implications in infancyRoger W Byard, Kartik D Bhatia, Peter L Reilly, et al.
Pageof 13